Global COVID-19 Drugs Market Growth (Status and Outlook) 2021-2026
According to this study, over the next five years the COVID-19 Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2026, from $ xx million in 2020.Specially this report presents the global revenue market share of key companies in COVID-19 Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by product type:
Tablet
Injection
Segmentation by Application:
Mild Symptom Patient
Critically Ill Patient
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Bayer
Rising Pharmaceutical
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COVID-19 Drugs Market Size 2021-2026
2.1.2 COVID-19 Drugs Market Size CAGR by Region
2.2 COVID-19 Drugs Segment by Type
2.2.1 Tablet
2.2.2 Injection
2.3 COVID-19 Drugs Market Size by Type
2.3.1 Global COVID-19 Drugs Market Size Market Share by Type (2021-2026)
2.3.2 Global COVID-19 Drugs Market Size Growth Rate by Type (2021-2026)
2.4 COVID-19 Drugs Segment by Application
2.4.1 Mild Symptom Patient
2.4.2 Critically Ill Patient
2.5 COVID-19 Drugs Market Size by Application
2.5.1 Global COVID-19 Drugs Market Size Market Share by Application (2021-2026)
2.5.2 Global COVID-19 Drugs Market Size Growth Rate by Application (2021-2026)
3 COVID-19 Drugs Key Players
3.1 Date of Key Players Enter into COVID-19 Drugs
3.2 Key Players COVID-19 Drugs Product Offered
3.3 Key Players COVID-19 Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 COVID-19 Drugs by Regions
4.1 COVID-19 Drugs Market Size by Regions (2021-2026)
4.2 Americas COVID-19 Drugs Market Size Growth (2021-2026)
4.3 APAC COVID-19 Drugs Market Size Growth (2021-2026)
4.4 Europe COVID-19 Drugs Market Size Growth (2021-2026)
5 Americas
5.1 Americas COVID-19 Drugs Market Size by Countries (2021-2026)
5.2 Americas COVID-19 Drugs Market Size by Type (2021-2026)
5.3 Americas COVID-19 Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COVID-19 Drugs Market Size by Regions
6.2 APAC COVID-19 Drugs Market Size by Type (2021-2026)
6.3 APAC COVID-19 Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe COVID-19 Drugs by Countries (2021-2026)
7.2 Europe COVID-19 Drugs Market Size by Type (2021-2026)
7.3 Europe COVID-19 Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in COVID-19 Drugs
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 Sanofi
10.1.1 Sanofi Company Details
10.1.2 Sanofi COVID-19 Drugs Product Offered
10.1.3 Sanofi COVID-19 Drugs Market Size (2021 VS 2026)
10.1.4 Sanofi Main Business Overview
10.1.5 Sanofi News
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Novartis COVID-19 Drugs Product Offered
10.2.3 Novartis COVID-19 Drugs Market Size (2021 VS 2026)
10.2.4 Novartis Main Business Overview
10.2.5 Novartis News
10.3 Shanghai Zhongxisanwei
10.3.1 Shanghai Zhongxisanwei Company Details
10.3.2 Shanghai Zhongxisanwei COVID-19 Drugs Product Offered
10.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Market Size (2021 VS 2026)
10.3.4 Shanghai Zhongxisanwei Main Business Overview
10.3.5 Shanghai Zhongxisanwei News
10.4 Teva
10.4.1 Teva Company Details
10.4.2 Teva COVID-19 Drugs Product Offered
10.4.3 Teva COVID-19 Drugs Market Size (2021 VS 2026)
10.4.4 Teva Main Business Overview
10.4.5 Teva News
10.5 Zydus Cadila
10.5.1 Zydus Cadila Company Details
10.5.2 Zydus Cadila COVID-19 Drugs Product Offered
10.5.3 Zydus Cadila COVID-19 Drugs Market Size (2021 VS 2026)
10.5.4 Zydus Cadila Main Business Overview
10.5.5 Zydus Cadila News
10.6 Mylan
10.6.1 Mylan Company Details
10.6.2 Mylan COVID-19 Drugs Product Offered
10.6.3 Mylan COVID-19 Drugs Market Size (2021 VS 2026)
10.6.4 Mylan Main Business Overview
10.6.5 Mylan News
10.7 Apotex
10.7.1 Apotex Company Details
10.7.2 Apotex COVID-19 Drugs Product Offered
10.7.3 Apotex COVID-19 Drugs Market Size (2021 VS 2026)
10.7.4 Apotex Main Business Overview
10.7.5 Apotex News
10.8 Advanz Pharma
10.8.1 Advanz Pharma Company Details
10.8.2 Advanz Pharma COVID-19 Drugs Product Offered
10.8.3 Advanz Pharma COVID-19 Drugs Market Size (2021 VS 2026)
10.8.4 Advanz Pharma Main Business Overview
10.8.5 Advanz Pharma News
10.9 Sun Pharma
10.9.1 Sun Pharma Company Details
10.9.2 Sun Pharma COVID-19 Drugs Product Offered
10.9.3 Sun Pharma COVID-19 Drugs Market Size (2021 VS 2026)
10.9.4 Sun Pharma Main Business Overview
10.9.5 Sun Pharma News
10.10 Kyung Poong
10.10.1 Kyung Poong Company Details
10.10.2 Kyung Poong COVID-19 Drugs Product Offered
10.10.3 Kyung Poong COVID-19 Drugs Market Size (2021 VS 2026)
10.10.4 Kyung Poong Main Business Overview
10.10.5 Kyung Poong News
10.11 Ipca Laboratories
10.12 Hanlim Pharmaceutical
10.13 Bristol Laboratories
10.14 Bayer
10.15 Rising Pharmaceutical
10.16 Shanghai Pharma
10.17 Sichuan Sunny Hope
10.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
10.19 CSPC Group
10.20 KPC Group
10.21 Jinghua Pharmaceutical Group
10.22 Zhongsheng Pharma
10.23 North China Pharmaceutical Group
11 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. COVID-19 Drugs Market Size CAGR by Region (2021-2026) ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Injection
Table 4. Global COVID-19 Drugs Market Size by Type (2021-2026) ($ Millions)
Table 5. Global COVID-19 Drugs Market Size Market Share by Type (2021-2026)
Table 6. Global COVID-19 Drugs Market Size by Application (2021-2026) ($ Millions)
Table 7. Global COVID-19 Drugs Market Size Market Share by Application (2021-2026)
Table 8. Date of Global Key Players Enter into COVID-19 Drugs Market
Table 9. Global Key Players COVID-19 Drugs Product Offered
Table 10. Key Players COVID-19 Drugs Funding/Investment ($ Millions)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End Industry
Table 13. Key Players COVID-19 Drugs Valuation & Market Capitalization ($ Millions)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. COVID-19 Drugs New Product/Technology Launches
Table 16. COVID-19 Drugs Industry Partnerships, Agreements, and Collaborations
Table 17. COVID-19 Drugs Industry Mergers and Acquisitions
Table 18. Global COVID-19 Drugs Market Size by Regions 2021-2026 ($ Millions)
Table 19. Global COVID-19 Drugs Market Size Market Share by Regions 2021-2026
Table 20. Americas COVID-19 Drugs Market Size by Countries (2021-2026) ($ Millions)
Table 21. Americas COVID-19 Drugs Market Size Market Share by Countries (2021-2026)
Table 22. Americas COVID-19 Drugs Market Size by Type (2021-2026) ($ Millions)
Table 23. Americas COVID-19 Drugs Market Size Market Share by Type (2021-2026)
Table 24. Americas COVID-19 Drugs Market Size by Application (2021-2026) ($ Millions)
Table 25. Americas COVID-19 Drugs Market Size Market Share by Application (2021-2026)
Table 26. APAC COVID-19 Drugs Market Size by Regions (2021-2026) ($ Millions)
Table 27. APAC COVID-19 Drugs Market Size Market Share by Regions (2021-2026)
Table 28. APAC COVID-19 Drugs Market Size by Type (2021-2026) ($ Millions)
Table 29. APAC COVID-19 Drugs Market Size Market Share by Type (2021-2026)
Table 30. APAC COVID-19 Drugs Market Size by Application (2021-2026) ($ Millions)
Table 31. APAC COVID-19 Drugs Market Size Market Share by Application (2021-2026)
Table 32. Europe COVID-19 Drugs Market Size by Countries (2021-2026) ($ Millions)
Table 33. Europe COVID-19 Drugs Market Size Market Share by Countries (2021-2026)
Table 34. Europe COVID-19 Drugs Market Size by Type (2021-2026) ($ Millions)
Table 35. Europe COVID-19 Drugs Market Size Market Share by Type (2021-2026)
Table 36. Europe COVID-19 Drugs Market Size by Application (2021-2026) ($ Millions)
Table 37. Europe COVID-19 Drugs Market Size Market Share by Application (2021-2026)
Table 38. Key and Potential Regions of COVID-19 Drugs
Table 39. Key Application and Potential Industries of COVID-19 Drugs
Table 40. Key Challenges of COVID-19 Drugs
Table 41. Key Trends of COVID-19 Drugs
Table 42. Company A Company Details
Table 43. Companies Invested by Company A
Table 44. Company A Key Development and Market Layout
Table 45. Company B Company Details
Table 46. Companies Invested by Company B
Table 47. Company B Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Company C Company Details
Table 52. Companies Invested by Company C
Table 53. Company C Key Development and Market Layout
Table 54. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Sanofi COVID-19 Drugs Market Size (2021 VS 2026)
Table 56. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Novartis COVID-19 Drugs Market Size (2021 VS 2026)
Table 58. Shanghai Zhongxisanwei Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Shanghai Zhongxisanwei COVID-19 Drugs Market Size (2021 VS 2026)
Table 60. Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Teva COVID-19 Drugs Market Size (2021 VS 2026)
Table 62. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Zydus Cadila COVID-19 Drugs Market Size (2021 VS 2026)
Table 64. Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Mylan COVID-19 Drugs Market Size (2021 VS 2026)
Table 66. Apotex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Apotex COVID-19 Drugs Market Size (2021 VS 2026)
Table 68. Advanz Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Advanz Pharma COVID-19 Drugs Market Size (2021 VS 2026)
Table 70. Sun Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Sun Pharma COVID-19 Drugs Market Size (2021 VS 2026)
Table 72. Kyung Poong Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Kyung Poong COVID-19 Drugs Market Size (2021 VS 2026)
Table 74. Ipca Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Ipca Laboratories COVID-19 Drugs Market Size (2021 VS 2026)
Table 76. Hanlim Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Hanlim Pharmaceutical COVID-19 Drugs Market Size (2021 VS 2026)
Table 78. Bristol Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Bristol Laboratories COVID-19 Drugs Market Size (2021 VS 2026)
Table 80. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 81. Bayer COVID-19 Drugs Market Size (2021 VS 2026)
Table 82. Rising Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 83. Rising Pharmaceutical COVID-19 Drugs Market Size (2021 VS 2026)
Table 84. Shanghai Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 85. Shanghai Pharma COVID-19 Drugs Market Size (2021 VS 2026)
Table 86. Sichuan Sunny Hope Basic Information, Head Office, Major Market Areas and Its Competitors
Table 87. Sichuan Sunny Hope COVID-19 Drugs Market Size (2021 VS 2026)
Table 88. Guangzhou Baiyunshan Guanghua Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 89. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Market Size (2021 VS 2026)
Table 90. CSPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 91. CSPC Group COVID-19 Drugs Market Size (2021 VS 2026)
Table 92. KPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 93. KPC Group COVID-19 Drugs Market Size (2021 VS 2026)
Table 94. Jinghua Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 95. Jinghua Pharmaceutical Group COVID-19 Drugs Market Size (2021 VS 2026)
Table 96. Zhongsheng Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 97. Zhongsheng Pharma COVID-19 Drugs Market Size (2021 VS 2026)
Table 98. North China Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 99. North China Pharmaceutical Group COVID-19 Drugs Market Size (2021 VS 2026)
List of Figures
Figure 1. Picture of COVID-19 Drugs
Figure 2. COVID-19 Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 Drugs Market Size Growth Rate 2021-2026 ($ Millions)
Figure 7. COVID-19 Drugs Market Size by Region (2021 & 2026) ($ millions)
Figure 8. Global COVID-19 Drugs Market Size Market Share by Type (2021-2026)
Figure 9. Global Tablet Market Size Growth Rate
Figure 10. Global Injection Market Size Growth Rate
Figure 11. COVID-19 Drugs in Mild Symptom Patient
Figure 12. Global COVID-19 Drugs Market: Mild Symptom Patient (2021-2026) ($ Millions)
Figure 13. COVID-19 Drugs in Critically Ill Patient
Figure 14. Global COVID-19 Drugs Market: Critically Ill Patient (2021-2026) ($ Millions)
Figure 15. Global COVID-19 Drugs Market Size Market Share by Application (2021-2026)
Figure 16. Global COVID-19 Drugs Market Size in Mild Symptom Patient Growth Rate
Figure 17. Global COVID-19 Drugs Market Size in Critically Ill Patient Growth Rate
Figure 18. Funding/Investment
Figure 19. Global COVID-19 Drugs Market Size Market Share by Regions 2021-2026
Figure 20. Americas COVID-19 Drugs Market Size 2021-2026 ($ Millions)
Figure 21. APAC COVID-19 Drugs Market Size 2021-2026 ($ Millions)
Figure 22. Europe COVID-19 Drugs Market Size 2021-2026 ($ Millions)
Figure 23. Americas COVID-19 Drugs Market Size Market Share by Countries in 2020
Figure 24. Americas COVID-19 Drugs Market Size Market Share by Type in 2020
Figure 25. Americas COVID-19 Drugs Market Size Market Share by Application in 2020
Figure 26. United States COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 27. Canada COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 28. Mexico COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 29. Brazil COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 30. APAC COVID-19 Drugs Market Size Market Share by Regions in 2020
Figure 31. APAC COVID-19 Drugs Market Size Market Share by Type in 2020
Figure 32. APAC COVID-19 Drugs Market Size Market Share by Application in 2020
Figure 33. China COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 34. Japan COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 35. Korea COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 36. Southeast Asia COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 37. India COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 38. Australia COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 39. Europe COVID-19 Drugs Market Size Market Share by Countries in 2020
Figure 40. Europe COVID-19 Drugs Market Size Market Share by Type in 2020
Figure 41. Europe COVID-19 Drugs Market Size Market Share by Application in 2020
Figure 42. Germany COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 43. France COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 44. UK COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 45. Italy COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 46. Russia COVID-19 Drugs Market Size Growth 2021-2026 ($ Millions)
Reason to Buy
- Current and future of Others Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Others Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Others Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Others Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets